Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of initial clinical suspicion on the diagnostic yield of laboratory enzymatic testing in lysosomal storage disorders. Experience from a multispecialty hospital.
Carnicer-Cáceres C, Villena-Ortiz Y, Castillo-Ribelles L, Barquín-Del-Pino R, Camprodon-Gomez M, Felipe-Rucián A, Moreno-Martínez D, Lucas-Del-Pozo S, Hernández-Vara J, García-Serra A, Tigri-Santiña A, Moltó-Abad M, Agraz-Pamplona I, Rodriguez-Palomares JF, Limeres-Freire J, Macaya-Font M, Rodríguez-Sureda V, Miguel LD, Del-Toro-Riera M, Pintos-Morell G, Arranz-Amo JA. Carnicer-Cáceres C, et al. Among authors: agraz pamplona i. Blood Cells Mol Dis. 2023 Jan;98:102704. doi: 10.1016/j.bcmd.2022.102704. Epub 2022 Oct 5. Blood Cells Mol Dis. 2023. PMID: 36265282
Avacopan for the Treatment of ANCA-Associated Vasculitis.
Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Jayne DRW, et al. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. N Engl J Med. 2021. PMID: 33596356 Clinical Trial.
Biological markers of nephrotic syndrome: a few steps forward in the long way.
Segarra-Medrano A, Carnicer-Cáceres C, Arbós-Via MA, Quiles-Pérez MT, Agraz-Pamplona I, Ostos-Roldán E. Segarra-Medrano A, et al. Nefrologia. 2012;32(5):558-72. doi: 10.3265/Nefrologia.pre2012.Jun.11396. Nefrologia. 2012. PMID: 23013941 Free article. Review. English, Spanish.
Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E, Segarra Medrano A, Carnicer Cáceres C, Martín-Gómez MA, Salcedo Allende MT, Ostos Roldan H, Agraz Pamplona I. Jatem Escalante E, et al. Nefrologia. 2015;35(5):479-86. doi: 10.1016/j.nefro.2015.05.026. Epub 2015 Jul 7. Nefrologia. 2015. PMID: 26306972 Free article. English, Spanish.
Study of the variables associated with local complement activation in IgA nephropathy.
Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E. Segarra-Medrano A, et al. Nefrologia. 2017 May-Jun;37(3):320-329. doi: 10.1016/j.nefro.2016.11.019. Epub 2017 May 8. Nefrologia. 2017. PMID: 28495395 Free article. English, Spanish.
Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E. Segarra-Medrano A, et al. Nefrologia. 2017 Sep-Oct;37(5):531-538. doi: 10.1016/j.nefro.2016.11.017. Nefrologia. 2017. PMID: 28946966 Free article. English, Spanish.
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up.
Carnicer-Cáceres C, Arranz-Amo JA, Cea-Arestin C, Camprodon-Gomez M, Moreno-Martinez D, Lucas-Del-Pozo S, Moltó-Abad M, Tigri-Santiña A, Agraz-Pamplona I, Rodriguez-Palomares JF, Hernández-Vara J, Armengol-Bellapart M, Del-Toro-Riera M, Pintos-Morell G. Carnicer-Cáceres C, et al. J Clin Med. 2021 Apr 13;10(8):1664. doi: 10.3390/jcm10081664. J Clin Med. 2021. PMID: 33924567 Free PMC article. Review.
Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors.
Segarra-Medrano A, Jatem-Escalante E, Agraz-Pamplona I, Carnicer-Cáceres C, Ramos-Terrades N, Ostos-Roldán E, Quiles-Pérez MT, Arbós-Via MA. Segarra-Medrano A, et al. Nefrologia. 2013;33(4):448-61. doi: 10.3265/Nefrologia.pre2013.Jan.11871. Nefrologia. 2013. PMID: 23897176 Free article. Review. English, Spanish.
Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A, Jatem-Escalante E, Quiles-Pérez MT, Salcedo MT, Arbós-Via MA, Ostos H, Valtierra N, Carnicer-Cáceres C, Agraz-Pamplona I. Segarra-Medrano A, et al. Nefrologia. 2014 May 21;34(3):353-9. doi: 10.3265/Nefrologia.pre2013.Dec.12291. Epub 2014 Feb 10. Nefrologia. 2014. PMID: 24798555 Free article. English, Spanish.
Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.
Segarra-Medrano A, Jatem-Escalante E, Carnicer-Cáceres C, Agraz-Pamplona I, Salcedo MT, Valtierra N, Ostos-Roldán E, Arredondo KV, Jaramillo J. Segarra-Medrano A, et al. Nefrologia. 2014;34(4):491-7. doi: 10.3265/Nefrologia.pre2014.Jun.12536. Nefrologia. 2014. PMID: 25036063 Free article. English, Spanish.
24 results